ArticleClinical pharmacology and therapeutics2020
Off-Label Therapies for COVID-19-Are We All In This Together?
Article in Clinical pharmacology and therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Remdesivir for the treatment of COVID-19.The Cochrane database of systematic reviews · 2023Pooled it
- Remdesivir for the treatment of COVID-19.The Cochrane database of systematic reviews · 2021Pooled it
- Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions.Pharmacological research · 2020Pooled it
- Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.Journal of medicinal chemistry · 2022Review
- Assessment of novel technologies in healthcare - off-label use of drugs and the ethics of implementation and distribution of COVID-19 vaccines.Einstein (Sao Paulo, Brazil) · 2022Article
- Pediatric Off-Label Use of Covid-19 Vaccines: Ethical and Legal Considerations.The Hastings Center report · 2021Article
- Inflammatory arthritis in patients with COVID-19.Translational research : the journal of laboratory and clinical medicine · 2021Review
- Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.Bioscience reports · 2021Review
- Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients' characteristics: a review of the literature and simulations.Xenobiotica; the fate of foreign compounds in biological systems · 2021Review
- Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology.Clinical pharmacology and therapeutics · 2020Review
- Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.International journal of cardiology · 2020Article
- Coordinating the research response to COVID-19: Mali's approach.Health research policy and systems · 2020Article
- COVID-19 - The Availability of ICU Beds in Brazil during the Onset of Pandemic.Annals of global health · 2020Article
- SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells.International journal of molecular sciences · 2020Review
- The Battle against COVID 19 Pandemic: What we Need to Know Before we "Test Fire" Ivermectin.Drug research · 2020Article
- Ethical Issues in Decision-making Regarding the Elderly Affected by Coronavirus Disease 2019: An Expert Opinion.European cardiology · 2020Review
- Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic.Frontiers in medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.